blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3156494

EP3156494 - GENOME EDITING IN RATS USING ZINC-FINGER NUCLEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2019
Database last updated on 10.07.2024
FormerThe patent has been granted
Status updated on  23.03.2018
FormerGrant of patent is intended
Status updated on  09.03.2018
FormerRequest for examination was made
Status updated on  22.02.2018
FormerGrant of patent is intended
Status updated on  15.10.2017
FormerRequest for examination was made
Status updated on  20.03.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS
published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Sangamo Therapeutics, Inc.
Point Richmond Tech Center
501 Canal Blvd., Suite A100
Richmond, CA 94804 / US
For all designated states
Sigma-Aldrich Co. LLC
3050 Spruce Street
St. Louis, MO 63103 / US
[2018/42]
Former [2018/35]For all designated states
Sangamo Therapeutics, Inc.
Point Richmond Tech Center
501 Canal Blvd., Suite A100
Richmond, CA 94804 / US
For all designated states
Sigma-Aldrich Co.
3050 Spruce Street
St. Louis, MO 63103 / US
Former [2018/11]For all designated states
Sangamo Therapeutics, Inc.
Point Richmond Tech Center
501 Canal Blvd., Suite A100
Richmond, CA 94804 / US
For all designated states
Sigma Aldrich Company
3050 Spruce Street
St. Louis, MO 63103 / US
Former [2017/16]For all designated states
Sangamo BioSciences, Inc.
Point Richmond Tech. Center
501 Canal Boulevard, Suite A100
Richmond, CA 94804 / US
For all designated states
Sigma Aldrich Company
3050 Spruce Street
St. Louis, MO 63103 / US
Inventor(s)01 / CUI, Xiaoxia
1231 Craig Road
St. Louis, MO 63146 / US
02 / GEURTS, Aron M.
13370 Sunburst Ct.
New Berlin, WI 53151 / US
03 / URNOV, Fyodor
c/o Sangamo Therapeutics, Inc.
Point Richmond Tech Center
501 Canal Boulevard, Suite A100
Richmond, CA 94804 / US
 [2018/17]
Former [2017/22]01 / CUI, Xiaoxia
1231 Craig Road
St. Louis, MO 63146 / US
02 / GEURTS, Aron M.
13370 Sunburst Ct.
New Berlin, WI 53151 / US
03 / URNOV, Fyodor
c/o Sangamo BioSciences Inc.
Point Richmond Tech Center
501 Canal Boulevard, Suite A100
Richmond, CA 94804 / US
Former [2017/16]01 / CUI, Xiaoxia
1231 Craig Road
St. Louis, MO 63146 / US
02 / GEURTS, Aron M.
12540 W. Wilbur Dr.
New Berlin, WI 53151 / US
03 / URNOV, Fyodor
c/o Sangamo BioSciences Inc.
Point Richmond Tech Center
501 Canal Boulevard, Suite A100
Richmond, CA 94804 / US
Representative(s)Weickmann & Weickmann PartmbB
Postfach 860 820
81635 München / DE
[2017/16]
Application number, filing date16200237.203.12.2009
[2017/16]
Priority number, dateUS20080200985P04.12.2008         Original published format: US 200985 P
US20090205970P26.01.2009         Original published format: US 205970 P
US20090263904P24.11.2009         Original published format: US 263904 P
[2017/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3156494
Date:19.04.2017
Language:EN
[2017/16]
Type: B1 Patent specification 
No.:EP3156494
Date:25.04.2018
Language:EN
[2018/17]
Type: B8 Corrected title page of specification 
No.:EP3156494
Date:19.09.2018
[2018/38]
Search report(s)(Supplementary) European search report - dispatched on:EP22.03.2017
ClassificationIPC:C12N15/85
[2017/16]
CPC:
A01K67/0275 (EP,US); C12N5/16 (KR); C12N15/907 (US);
A01K67/0276 (EP,US); A01K67/0278 (EP,KR,US); C12N15/1024 (US);
C12N15/11 (KR); C12N15/8509 (EP,KR,US); C12N9/22 (EP,KR,US);
A01K2217/054 (EP,US); A01K2217/15 (EP,KR,US); A01K2227/10 (EP,US);
A01K2227/105 (EP,KR,US); A01K2267/03 (EP,US); A01K2267/0393 (EP,KR,US);
C07K2319/00 (EP,US); C07K2319/81 (EP,KR,US); C12N2015/8527 (US);
C12N2015/8536 (KR); C12N2800/80 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/16]
TitleGerman:GENOMÄNDERUNG BEI RATTEN MITHILFE VON ZINK-FINGER-NUKLEASEN[2017/16]
English:GENOME EDITING IN RATS USING ZINC-FINGER NUCLEASES[2017/16]
French:ÉDITION DE GÉNOME CHEZ DES RATS AU MOYEN DE NUCLÉASES EN DOIGT DE ZINC[2017/16]
Examination procedure23.11.2016Examination requested  [2017/16]
23.11.2016Date on which the examining division has become responsible
04.09.2017Amendment by applicant (claims and/or description)
16.10.2017Communication of intention to grant the patent
19.02.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
19.02.2018Fee for grant paid
19.02.2018Fee for publishing/printing paid
08.03.2018Information about intention to grant a patent
08.03.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09830727.5  / EP2352369
Opposition(s)28.01.2019No opposition filed within time limit [2019/14]
Fees paidRenewal fee
23.11.2016Renewal fee patent year 03
23.11.2016Renewal fee patent year 04
23.11.2016Renewal fee patent year 05
23.11.2016Renewal fee patent year 06
23.11.2016Renewal fee patent year 07
23.11.2016Renewal fee patent year 08
12.12.2017Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.12.2009
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
MK25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
IS25.08.2018
PT27.08.2018
GB03.12.2018
IE03.12.2018
LU03.12.2018
MT03.12.2018
BE31.12.2018
[2020/32]
Former [2020/31]HU03.12.2009
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
MK25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
GB03.12.2018
IE03.12.2018
LU03.12.2018
MT03.12.2018
BE31.12.2018
Former [2020/16]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
GB03.12.2018
IE03.12.2018
LU03.12.2018
MT03.12.2018
BE31.12.2018
Former [2020/08]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
GB03.12.2018
IE03.12.2018
LU03.12.2018
MT03.12.2018
BE31.12.2018
Former [2020/03]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
GB03.12.2018
IE03.12.2018
LU03.12.2018
BE31.12.2018
Former [2019/51]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
IE03.12.2018
LU03.12.2018
BE31.12.2018
Former [2019/48]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
IE03.12.2018
LU03.12.2018
Former [2019/40]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
LU03.12.2018
Former [2019/39]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
LU03.12.2018
Former [2019/26]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/11]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
IT25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/10]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
RO25.04.2018
SE25.04.2018
SK25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/09]DK25.04.2018
EE25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/08]DK25.04.2018
ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/03]ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2018/52]ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
Former [2018/51]ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/50]ES25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/49]ES25.04.2018
FI25.04.2018
LT25.04.2018
NL25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/47]ES25.04.2018
FI25.04.2018
LT25.04.2018
NL25.04.2018
NO25.07.2018
Former [2018/43]NL25.04.2018
Documents cited:Search[A]EP1348335  (BOEHRINGER INGELHEIM INT [DE]) [A] 1-10 * the whole document *;
 [A]WO03080809  (STELL [US], et al) [A] 1-10 * the whole document *;
 [A]WO03087341  (UNIV UTAH RES FOUND [US], et al) [A] 1-10 * claims 1-89 *;
 [AP]WO2008151081  (OMT INC [US], et al) [AP] 1-10* the whole document *;
 [AP]US2009205083  (GUPTA MANJU [US], et al) [AP] 1-10 * the whole document *;
 [A]  - MILLER JEFFREY C ET AL, "An improved zinc-finger nuclease architecture for highly specific genome editing", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20070701), vol. 25, no. 7, doi:10.1038/NBT1319, ISSN 1087-0156, pages 778 - 785, XP002465119 [A] 1-10 * figures 1,2 *

DOI:   http://dx.doi.org/10.1038/nbt1319
 [A]  - URNOV F D ET AL, "Highly efficient endogenous human gene correction using designed zinc-finger nucleases", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM, (20050602), vol. 435, no. 7042, doi:10.1038/NATURE03556, ISSN 0028-0836, pages 646 - 651, XP002411069 [A] 1-10 * figures 1-6 *

DOI:   http://dx.doi.org/10.1038/nature03556
 [A]  - PORTEUS M H ET AL, "GENE TARGETING USING ZINC FINGER NUCLEASES", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20050801), vol. 23, no. 8, doi:10.1038/NBT1125, ISSN 1087-0156, pages 967 - 973, XP002467422 [A] 1-10 * figure 2 *

DOI:   http://dx.doi.org/10.1038/nbt1125
 [A]  - DOYON Y ET AL, "Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases", NATURE BIOTECHNOLOGY, GALE GROUP INC, US, vol. 26, no. 6, doi:10.1038/NBT1409, ISSN 1087-0156, (20080601), pages 702 - 708, (20080525), XP002512110 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1038/NBT1409
 [A]  - MENG XIANGDONG ET AL, "Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases", NATURE BIOTECHNOLOGY, GALE GROUP INC, US, vol. 26, no. 6, doi:10.1038/NBT1398, ISSN 1087-0156, (20080601), pages 695 - 701, (20080525), XP002512111 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1038/NBT1398
by applicantUS4186183
 US4217344
 US4235871
 US4261975
 US4485054
 US4501728
 US4774085
 US4837028
 US4897355
 US4946787
 US5049386
 WO9116024
 WO9117424
 US5176996
 US5356802
 US5420032
 US5422251
 WO9519431
 US5436150
 US5487994
 WO9606166
 US5585245
 US5789538
 WO9837186
 WO9844350
 WO9853058
 WO9853059
 WO9853060
 WO9853057
 WO9854311
 US5925523
 GB2338237
 US6007988
 US6008336
 US6013453
 WO0027878
 US6140081
 US6140466
 US6200759
 US6242568
 WO0160970
 WO0188197
 WO0216536
 US6410248
 US6453242
 WO02077227
 US6479626
 WO02099084
 US6503717
 WO03016496
 US6534261
 US6599692
 US6607882
 US2003232410
 US6689558
 US6824978
 US6833252
 US2005026157
 US2005064474
 US6903185
 US6933113
 US2005208489
 US6979539
 US7013219
 US2006063231
 US2006188987
 US7153949
 US7163824
 WO2007014275
 US2007134796
 US2007218528
 US2008015164
 US2008015996
 US2008131962
 US2008159996
 WO2008133938
    - MICHALKIEWICZ ET AL., J. AMER. PHYS. SOCIETY, (2007), vol. 293, pages H881 - H894
    - METHODS IN ENZYMOLOGY, ACADEMIC PRESS
    - "Chromatin", P.M. WASSARMAN AND A. P. WOLFFE, METHODS IN ENZYMOLOGY, ACADEMIC PRESS, (1999), vol. 304
    - "Chromatin Protocols", P.B. BECKER, METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS, (1999), vol. 119
    - SMITH; WATERMAN, ADVANCES IN APPLIED MATHEMATICS, (1981), vol. 2, pages 482 - 489
    - DAYHOFF, Atlas of Protein Sequences and Structure, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, vol. 5, pages 353 - 358
    - GRIBSKOV, NUCL. ACIDS RES., (1986), vol. 14, no. 6, pages 6745 - 6763
    - FIELDS ET AL., NATURE, (1989), vol. 340, pages 245 - 246
    - BEERLI ET AL., NATURE BIOTECHNOL., (2002), vol. 20, pages 135 - 141
    - PABO ET AL., ANN. REV. BIOCHEM., (2001), vol. 70, pages 313 - 340
    - ISALAN ET AL., NATURE BIOTECHNOL., (2001), vol. 19, pages 656 - 660
    - SEGAL ET AL., CURR. OPIN. BIOTECHNOL., (2001), vol. 12, pages 632 - 637
    - CHOO ET AL., CURR. OPIN. STRUCT. BIOL., (2000), vol. 10, pages 411 - 416
    - BELFORT ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, pages 3379 - 3388
    - LI ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 4275 - 4279
    - LI ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 2764 - 2768
    - KIM ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 883 - 887
    - KIM ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 31,978 - 31,982
    - BITINAITE ET AL., PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 10,570 - 10,575
    - ROBERTS ET AL., NUCLEIC ACIDS RES., (2003), vol. 31, pages 418 - 420
    - DUJON ET AL., GENE, (1989), vol. 82, pages 115 - 118
    - PERLER ET AL., NUCLEIC ACIDS RES., (1994), vol. 22, pages 1125 - 1127
    - JASIN, TRENDS GENET., (1996), vol. 12, pages 224 - 228
    - GIMBLE ET AL., J. MOL. BIOL., (1996), vol. 263, pages 163 - 180
    - ARGAST ET AL., J. MOL. BIOL., (1998), vol. 280, pages 345 - 353
    - CHEVALIER ET AL., MOLEC. CELL, (2002), vol. 10, pages 895 - 905
    - EPINAT ET AL., NUCLEIC ACIDS RES., (2003), vol. 31, pages 2952 - 2962
    - ASHWORTH ET AL., NATURE, (2006), vol. 441, pages 656 - 659
    - PAQUES ET AL., CURRENT GENE THERAPY, (2007), vol. 7, pages 49 - 66
    - HAMMERSCHMIDT ET AL., METHODS CELL BIOL., (1999), vol. 59, pages 87 - 115
    - CRYSTAL, SCIENCE, (1995), vol. 270, pages 404 - 410
    - BLAESE ET AL., CANCER GENE THER, (1995), vol. 2, pages 291 - 297
    - BEHR ET AL., BIOCONJUGATE CHEM, (1994), vol. 5, pages 382 - 389
    - REMY ET AL., BIOCONJUGATE CHEM., (1994), vol. 5, pages 647 - 654
    - GAO ET AL., GENE THERAPY, (1995), vol. 2, pages 710 - 722
    - AHMAD ET AL., CANCER RES., (1992), vol. 52, pages 4817 - 4820
    - URNOV ET AL., NATURE, (2005), vol. 435, no. 7042, pages 646 - 651
    - DOYON ET AL., NATURE BIOTECHNOLOGY, (2008), vol. 26, no. 6, pages 702 - 708
    - FILIPIAK ET AL., TRANSGENIC RES, (2006), vol. 15, pages 673 - 686
    - LLOYD ET AL., PROC NATL ACAD SCI USA, (2005), vol. 102, pages 2232 - 2237
    - SCIENCE, (2009), vol. 325, page 433
 US20040912932
 US20050721054
 US20080284887
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.